|
Video: What is a Stock Split?
|
|
Virpax Pharmaceuticals is a preclinical stage biopharmaceutical company focused on becoming an pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Co. is developing branded pharmaceutical product candidates for pain management by using advanced technology in an effort to enhance patients' quality of life. According to our Virpax Pharmaceuticals stock split history records, Virpax Pharmaceuticals has had 1 split. | |
|
Virpax Pharmaceuticals (VRPX) has 1 split in our Virpax Pharmaceuticals stock split history database. The split for VRPX took place on March 01, 2024. This was a 1 for 10 reverse split, meaning for each 10 shares of VRPX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as Virpax Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Virpax Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Virpax Pharmaceuticals shares, starting with a $10,000 purchase of VRPX, presented on a split-history-adjusted basis factoring in the complete Virpax Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
02/18/2021 |
|
End date: |
04/17/2024 |
|
Start price/share: |
$61.00 |
|
End price/share: |
$3.47 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.31% |
|
Average Annual Total Return: |
-59.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$568.72 |
|
Years: |
3.16 |
|
|
|
Date |
Ratio |
03/01/2024 | 1 for 10 |
|
|